1. Home
  2. PTGX vs SGHC Comparison

PTGX vs SGHC Comparison

Compare PTGX & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • SGHC
  • Stock Information
  • Founded
  • PTGX 2006
  • SGHC 2020
  • Country
  • PTGX United States
  • SGHC Guernsey
  • Employees
  • PTGX N/A
  • SGHC N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • SGHC Services-Misc. Amusement & Recreation
  • Sector
  • PTGX Health Care
  • SGHC Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • SGHC Nasdaq
  • Market Cap
  • PTGX 3.3B
  • SGHC 4.9B
  • IPO Year
  • PTGX 2016
  • SGHC N/A
  • Fundamental
  • Price
  • PTGX $51.25
  • SGHC $11.40
  • Analyst Decision
  • PTGX Strong Buy
  • SGHC Strong Buy
  • Analyst Count
  • PTGX 9
  • SGHC 6
  • Target Price
  • PTGX $67.11
  • SGHC $11.50
  • AVG Volume (30 Days)
  • PTGX 1.0M
  • SGHC 1.5M
  • Earning Date
  • PTGX 08-05-2025
  • SGHC 08-06-2025
  • Dividend Yield
  • PTGX N/A
  • SGHC 1.36%
  • EPS Growth
  • PTGX N/A
  • SGHC 278.66
  • EPS
  • PTGX 0.86
  • SGHC 0.27
  • Revenue
  • PTGX $207,801,000.00
  • SGHC $1,939,039,555.00
  • Revenue This Year
  • PTGX N/A
  • SGHC $18.57
  • Revenue Next Year
  • PTGX $47.15
  • SGHC $9.31
  • P/E Ratio
  • PTGX $59.19
  • SGHC $42.19
  • Revenue Growth
  • PTGX N/A
  • SGHC 21.70
  • 52 Week Low
  • PTGX $32.50
  • SGHC $2.94
  • 52 Week High
  • PTGX $60.60
  • SGHC $11.40
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 45.80
  • SGHC 81.69
  • Support Level
  • PTGX $49.86
  • SGHC $10.61
  • Resistance Level
  • PTGX $57.24
  • SGHC $11.18
  • Average True Range (ATR)
  • PTGX 2.06
  • SGHC 0.35
  • MACD
  • PTGX -0.78
  • SGHC 0.11
  • Stochastic Oscillator
  • PTGX 16.14
  • SGHC 99.51

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About SGHC Super Group (SGHC) Limited

Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.

Share on Social Networks: